Lead Discovery Center GmbH:製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Lead Discovery Center GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C10623)・商品コード:DATA904C10623
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:41
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Lead Discovery Center GmbH (LDC), a subsidiary of Max Planck Innovation GmbH is a biomedical research company that offers development of novel drugs and therapies. The company develops drugs and therapies for diseases such as neurodegenerative cardiovascular diseases, cancer, inflammatory disorders, inflammatory disorders and infections, metabolic syndrome, and unmet clinical needs. It offers services such as medical chemistry through organic synthesis, design of focused compound libraries, establishment of structure-activity, computer-aided rational drug design, and structure-property relationships, among others. LDC offers services through its departments including assay development and screening, medicinal chemistry, biology and pharmacology. The company collaborates with universities and academic research institutions for professional drug discovery support. LDC is headquartered in Dortmund, Germany.

Lead Discovery Center GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
UGISense Raises Funds through Financing 12
UGISense to Raise USD1.3 Million Venture Financing 13
Partnerships 14
APEIRON Biologics Enters into Agreement with Lead Discovery Center 14
Grunenthal, Lead Discovery Center, Max-Planck Innovation and Max Planck Institute of Experimental Medicine Enter into Agreement 15
Daiichi Sankyo, Max Planck Innovation and Lead Discovery Center Enter into Research Agreement 16
Arix Bioscience, Lead Discovery Center, Max Planck Innovation and University of Leeds Enter into Partnership 17
Lead Discovery Center to Enter into Development Agreement with UGISense 18
Lead Discovery Center Enters into Research Agreement with McGill University 19
LDC, Max Planck Innovation Enters into Agreement with Boehringer Ingelheim 20
Lead Discovery Center to Enter into Drug Discovery Agreement with Roche 21
Lead Discovery Center Partners with Infinity Pharma 22
Johnson & Johnson Innovation Partners with Lead Discovery Center 23
Qurient Enters into Agreement with Lead Discovery Center 24
AstraZeneca Expands Drug Discovery Agreement with Lead Discovery Center 25
Lead Discovery Center Enters into Research Agreement with Helmholtz Center 26
Lead Discovery Center Enters into Agreement with UiT The Arctic University of Norway 27
Lead Discovery Center Partners with Helmholtz Association of German Research Centres 28
Daiichi Sankyo Enters Into Drug Discovery Agreement With Lead Discovery Center 29
Lead Discovery Center, Centre for Drug Design and Discovery and Axxam Form Joint Venture 30
Merck Serono Enters Into Discovery Agreement With Lead Discovery Center 31
AstraZeneca Enters Into Drug Discovery Agreement With Lead Discovery Center 32
Licensing Agreements 33
Sotio Enters into Licensing Agreement with Lead Discovery Center 33
Lead Discovery Center Enters into Licensing Agreement with Qurient 34
Qurient Enters Into Licensing Agreement with Max Planck Society and Lead Discovery Center 35
Max Planck Institute of Biochemistry And Lead Discovery Center Enter Into Licensing Agreement With Qurient For Kinase Inhibitor 36
Lead Discovery Center GmbH – Key Competitors 38
Lead Discovery Center GmbH – Key Employees 39
Lead Discovery Center GmbH – Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Joint Venture 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lead Discovery Center GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
UGISense Raises Funds through Financing 12
UGISense to Raise USD1.3 Million Venture Financing 13
APEIRON Biologics Enters into Agreement with Lead Discovery Center 14
Grunenthal, Lead Discovery Center, Max-Planck Innovation and Max Planck Institute of Experimental Medicine Enter into Agreement 15
Daiichi Sankyo, Max Planck Innovation and Lead Discovery Center Enter into Research Agreement 16
Arix Bioscience, Lead Discovery Center, Max Planck Innovation and University of Leeds Enter into Partnership 17
Lead Discovery Center to Enter into Development Agreement with UGISense 18
Lead Discovery Center Enters into Research Agreement with McGill University 19
LDC, Max Planck Innovation Enters into Agreement with Boehringer Ingelheim 20
Lead Discovery Center to Enter into Drug Discovery Agreement with Roche 21
Lead Discovery Center Partners with Infinity Pharma 22
Johnson & Johnson Innovation Partners with Lead Discovery Center 23
Qurient Enters into Agreement with Lead Discovery Center 24
AstraZeneca Expands Drug Discovery Agreement with Lead Discovery Center 25
Lead Discovery Center Enters into Research Agreement with Helmholtz Center 26
Lead Discovery Center Enters into Agreement with UiT The Arctic University of Norway 27
Lead Discovery Center Partners with Helmholtz Association of German Research Centres 28
Daiichi Sankyo Enters Into Drug Discovery Agreement With Lead Discovery Center 29
Lead Discovery Center, Centre for Drug Design and Discovery and Axxam Form Joint Venture 30
Merck Serono Enters Into Discovery Agreement With Lead Discovery Center 31
AstraZeneca Enters Into Drug Discovery Agreement With Lead Discovery Center 32
Sotio Enters into Licensing Agreement with Lead Discovery Center 33
Lead Discovery Center Enters into Licensing Agreement with Qurient 34
Qurient Enters Into Licensing Agreement with Max Planck Society and Lead Discovery Center 35
Max Planck Institute of Biochemistry And Lead Discovery Center Enter Into Licensing Agreement With Qurient For Kinase Inhibitor 36
Lead Discovery Center GmbH, Key Competitors 38
Lead Discovery Center GmbH, Key Employees 39
Lead Discovery Center GmbH, Subsidiaries 40
Lead Discovery Center GmbH, Joint Venture 40

List of Figures
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★調査レポート[Lead Discovery Center GmbH:製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C10623)販売に関する免責事項を必ずご確認ください。
★調査レポート[Lead Discovery Center GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆